Medica RCP |Mestinon | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Mestinon

Mestinon :
Type	Medicine Authorised
Originator	B
Agent	Omnipharma
Distributor	Omnipharma
Laboratory	Meda Pharmaceuticals
Responsible Party	Meda Manufacturing Switzerland GmbH
Origin	Switzerland
Manufacturer	ICN Polfa Rzeszow SA
Origin	Poland
ATC	N07AA02

Mestinon :

Oral

Mestinon :

N Nervous System

N07 Other nervous system drugs

N07A Parasympathomimetics

N07AA Anticholinesterases

N07AA02 Pyridostigmine

Mestinon :

Pyridostigmine : 60mg

Mestinon :

Atonic constipation 1 dragée as required, every 4 hrs

Intestinal atony 1 dragée as required, every 4 hrs

Myasthenia gravis pseudoparalytica 1-3 dragées BID-QDS

Mestinon :

Revision Date : 01/01/2016

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Abdominal cramps	Not known
Abdominal pain	Not known
Accommodation disorder	Not known
Arrhythmia	Not known
Atrioventricular block (AVB)	Not known
Bowel peristalsis increased	Not known
Bradycardia	Not known
Bronchial obstruction	Not known
Diarrhoea (Diarrhea)	Not known
Drug hypersensitivity	Not known
Exanthema	Rare
Fasciculation (Muscle fasciculation)	Not known
Flushing	Not known
Hyperhidrosis	Not known
Hypersalivation	Not known
Hypotension	Not known
Hypotonia (Muscle tone decreased)	Not known
Increased bronchial secretion	Not known
Lacrimation increased (Epiphora)	Not known
Miosis	Not known
Muscle weakness	Not known
Nausea	Not known
Polyuria	Not known
Prinzmetal angina	Not known
Psychosis	Not known
Skin Eruption	Rare
Syncope	Not known
Tachycardia	Not known
Tremor muscle	Not known
Urticaria	Not known
Vision blurred	Not known
Vomiting	Not known

Mestinon :

Abu Dhabi

Bahrain

Belgium

Czech Republic

Denmark

Egypt

Finland

France

Germany

Greece

Ireland

Italy

Jordan

KSA

Kuweit

Lebanon

New Zealand

Norway

Oman

Portugal

Qatar

Spain

Sweden

Switzerland

The Netherlands

Tunisia

Turkey

UAE

Medicine Authorised

Mestinon

P.P. : 3427023,6 LBP

( Box of 150 )

P/U: 22846,82 LBP

Omnipharma

Meda Pharmaceuticals

▲ Most Expensive

▼ Least Expensive

P.P. =	Public Price
P/U =	Price Per Unit

- Products with same active ingredients

- Products with same strength

- Products with same route of administration

Coming Very Soon

Different Units By MoH Code

Mestinon MoH 8459 :

Form Tablet, Sugar-Coated

Packaging Bottle (Glass)

Package Size Box of 150

Strength 60mg

Storage Condition <30°C None

Public Price 3427023,6 L.L.

Stratum B

NSSF ✔

Quarantine ✘

Reg. Number 173715/1

Submission date 01/01/2015

Registration Year 2016

Price Comparison

You have to register to view this info

Note

You have to register to view this info

Note

Prices are provided in Dollar ($)

You have to register to view this info

Visitors Count: 30971257

Form	Tablet, Sugar-Coated
Packaging	Bottle (Glass)
Package Size	Box of 150
Strength	60mg
Storage Condition	<30°C None
Public Price	3427023,6 L.L.
Stratum	B
NSSF	✔
Quarantine	✘
Reg. Number	173715/1
Submission date	01/01/2015
Registration Year	2016